Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s stock price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $9.73, but opened at $10.49. Phathom Pharmaceuticals shares last traded at $9.42, with a volume of 136,494 shares. The company reported ($0.80) earnings […]
Helicobacter Pylori Treatment MarketThe global helicobacter pylori infections treatment market is poised for remarkable growth, according to recent market analysis. Projections indicate that the market, valued at US$ 638.3 million in 2023, is expected to surge to a valuation of US$ 1,260 million by 2033, representin.
Newtyn Management LLC decreased its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 26.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 500,000 shares of the company’s stock after selling 183,648 shares during the quarter. Phathom Pharmaceuticals makes up 1.3% of Newtyn […]
If we are to achieve the clinical and economic benefits of primary care and care continuity, the implementation and evaluation of strategies that reward clinicians and patients are warranted.
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shot up 9.4% during trading on Tuesday . The company traded as high as $10.65 and last traded at $10.16. 351,678 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 761,808 shares. The stock had previously closed at $9.29. Analyst […]